[1. Burkitt Wright EMM, O’Connor R, Kerr BA. Radial aplasia in CHARGE syndrome: a new association. Eur J Med Genet. 2009; 52(4): 239-241.10.1016/j.ejmg.2009.03.017]Search in Google Scholar
[2. Koletzko B, Majewski F Congenital anomalies in patients with choanal atresia: CHARGE-association. Eur J Pediatr. 1984; 142(4): 271-275.10.1007/BF00540250]Search in Google Scholar
[3. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet. 2008; 83(4): 511-519.10.1016/j.ajhg.2008.09.005]Search in Google Scholar
[4. Vervloed MPJ, Hoevenaars-van den Boom MAA, Knoors H, van Ravenswaaij CMA, Admiraal RJC. CHARGE syndrome: Relations between behavioral characteristics and medical conditions. Am J Med Genet. 2006; 140A(8): 851-862.10.1002/ajmg.a.31193]Search in Google Scholar
[5. Graham JM. A recognizable syndrome within CHARGE association: Hall-Hittner syndrome. Am J Med Genet. 2001; 99(2): 120-123.10.1002/1096-8628(2000)9999:999<00::AID-AJMG1132>3.0.CO;2-J]Search in Google Scholar
[6. Hsu P, Ma A, Wilson M, Williams G, Curotta J, Munns CF, et al. CHARGE syndrome: a review. J Paediatr Child Health. 2014; 50(7): 504-511.10.1111/jpc.12497]Search in Google Scholar
[7. Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, (see above) et al. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature. 2010; 463(7283): 958-62.10.1038/nature08733]Search in Google Scholar
[8. Green GE, Huq FS, Emery SB, Mukherji SK, Martin DM. CHD7 muttions and CHARGE syndrome in semicircular canal dysplasia. Otol Neurotol. 2014; 35(8): 1466-1470.10.1097/MAO.0000000000000260]Search in Google Scholar
[9. Vatta M, Niu Z, Lupski JR, Putnam P, Spoonamore KG, Fang P, et al. Evidence for replicative mechanism in a CHD7 rearrangement in a patient with CHARGE syndrome. Am J Med Genet A. 2013; 161A(12): 3182-3186.10.1002/ajmg.a.36178]Search in Google Scholar
[10. Janssen N, Bergman JE, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012; 33(8): 1149-1160.10.1002/humu.22086]Search in Google Scholar
[11. Verloes A. Updated diagnostic criteria for CHARGE syndrome: aproposal. Am J Med Genet A. 2005; 133A(3): 306-308.10.1002/ajmg.a.3055915666308]Search in Google Scholar
[12. Issekutz KA, Graham JM Jr, Prasad C, Smith IM, Blake KD. An epidemiological analysis of CHARGE syndrome: Preliminary results from a Canadian study. Am J Med Genet A. 2005; 133A(3): 309-317.10.1002/ajmg.a.3056015637722]Search in Google Scholar
[13. Wessels K, Bohnhorst B, Luhmer I, Morlot S, Bohring A, Jonasson J, et al. Novel CHD7 mutations contributing to the mutation spectrum in patients with CHARGE syndrome. Eur J Med Genet. 2010; 53(5): 280-285.10.1016/j.ejmg.2010.07.00220624498]Search in Google Scholar
[14. Mitchell JA, Giangiacomo J, Hefner MA, Thelin JW, Pickens JM. Dominant CHARGE association. Ophthalmic Paediatr Genet. 1985; 6(1-2): 271-276.10.3109/13816818509004114]Search in Google Scholar
[15. Martinez-Quintana E, Rodriguez-Gonzalez F, Garay-Sanchez P, Tugores A. Novel frameshift CHD7 mutation related to CHARGE syndrome. Mol Syndromol. 2014; 5(1): 36-40.10.1159/000355431]Search in Google Scholar
[16. Lalani SR, Safiullah AM, Fernbach SD, Harutyunyan KG, Thaller C, Peterson LE, et al. Spec trum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet. 2006; 78(2): 303-314.10.1086/500273138023716400610]Search in Google Scholar
[17. Aramaki M, Udaka T, Kosaki R, Makita Y, Okamoto N, Yoshihashi H, et al. Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr. 2006; 148(3): 410-414.10.1016/j.jpeds.2005.10.04416615981]Search in Google Scholar
[18. Blake KD, Davenport SL, Hall BD, Hefner MA, Pagon RA, Williams MS, et al. CHARGE association: An update and review for the primary pediatrician. Clin Pediatr. 1998; 37(3): 159-173.10.1177/0009922898037003029545604]Search in Google Scholar
[19. Saladi SV, de la Serna IL. ATP dependent chromatin remodeling enzymes in emryonic stem cells. Stem Cell Rev. 2010; 6(1): 62-73.10.1007/s12015-010-9120-y286299220148317]Search in Google Scholar
[20. Bosman EA, Penn AC, Ambrose JC, Kettleborough R, Stemple DL, Steel KP. Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet. 2005; 14(22): 3463-3476.10.1093/hmg/ddi37516207732]Search in Google Scholar
[21. Bouazoune K, Kingston RE. Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders. Proc Natl Acad Sci USA. 2012; 109(47): 19238-19243.10.1073/pnas.1213825109351109723134727]Search in Google Scholar
[22. Vuorela P, Ala-Mello S, Saloranta C, Penttinen M, Pöyhönen M, Huoponen K, et al. Molecular analysis of the CHD7 gene in CHARGE syndrome: Identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions. Genet Med. 2007; 9(10): 690-694.10.1097/GIM.0b013e318156e68e18073582]Search in Google Scholar
[23. Chen JM, Férec C, Cooper DN. Patterns and mutational signatures of tandem base substitutions causing human inherited disease. Hum Mutat. 2013; 34(8): 1119-1130.10.1002/humu.2234123606422]Search in Google Scholar
[24. Chen JM1, Férec C, Cooper DN. Transient hypermutability, chromothripsis and replication-based mechanisms in the generation of concurrent clustered mutations. Mutat Res. 2012; 750(1): 52-59.10.1016/j.mrrev.2011.10.00222100908]Search in Google Scholar
[25. Johnson D, Morrison N, Grant L, Turner T, Fantes J, Connor JM, et al. Confirmation of CHD7 as a cause of CHARGE association identified by mapping a balanced chromosome translocation in affected monozygotic twins. J Med Genet. 2006; 43(3): 280-284. 10.1136/jmg.2005.032946256325116118347]Search in Google Scholar